SG65593A1 - Totally synthetic affinity reagents - Google Patents
Totally synthetic affinity reagentsInfo
- Publication number
- SG65593A1 SG65593A1 SG1996008235A SG1996008235A SG65593A1 SG 65593 A1 SG65593 A1 SG 65593A1 SG 1996008235 A SG1996008235 A SG 1996008235A SG 1996008235 A SG1996008235 A SG 1996008235A SG 65593 A1 SG65593 A1 SG 65593A1
- Authority
- SG
- Singapore
- Prior art keywords
- heterofunctional
- reagents
- peptide portion
- novel
- binding
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1048—SELEX
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3007—Carcino-embryonic Antigens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3069—Reproductive system, e.g. ovaria, uterus, testes, prostate
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1075—Isolating an individual clone by screening libraries by coupling phenotype to genotype, not provided for in other groups of this subclass
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/50—Fusion polypeptide containing protease site
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/61—Fusion polypeptide containing an enzyme fusion for detection (lacZ, luciferase)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/705—Fusion polypeptide containing domain for protein-protein interaction containing a protein-A fusion
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/73—Fusion polypeptide containing domain for protein-protein interaction containing coiled-coiled motif (leucine zippers)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/735—Fusion polypeptide containing domain for protein-protein interaction containing a domain for self-assembly, e.g. a viral coat protein (includes phage display)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Cell Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Oncology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Reproductive Health (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Sampling And Sample Adjustment (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US48042090A | 1990-02-15 | 1990-02-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG65593A1 true SG65593A1 (en) | 1999-06-22 |
Family
ID=23907894
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG1996008235A SG65593A1 (en) | 1990-02-15 | 1991-02-14 | Totally synthetic affinity reagents |
Country Status (8)
Country | Link |
---|---|
US (1) | US5935823A (de) |
EP (1) | EP0515516B1 (de) |
JP (1) | JP3043407B2 (de) |
AT (1) | ATE212059T1 (de) |
CA (1) | CA2075974C (de) |
DE (1) | DE69132902D1 (de) |
SG (1) | SG65593A1 (de) |
WO (1) | WO1991012328A1 (de) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5498538A (en) * | 1990-02-15 | 1996-03-12 | The University Of North Carolina At Chapel Hill | Totally synthetic affinity reagents |
US5747334A (en) * | 1990-02-15 | 1998-05-05 | The University Of North Carolina At Chapel Hill | Random peptide library |
US6916605B1 (en) | 1990-07-10 | 2005-07-12 | Medical Research Council | Methods for producing members of specific binding pairs |
GB9015198D0 (en) * | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
US7063943B1 (en) | 1990-07-10 | 2006-06-20 | Cambridge Antibody Technology | Methods for producing members of specific binding pairs |
US5525491A (en) * | 1991-02-27 | 1996-06-11 | Creative Biomolecules, Inc. | Serine-rich peptide linkers |
US5733731A (en) * | 1991-10-16 | 1998-03-31 | Affymax Technologies N.V. | Peptide library and screening method |
ATE408012T1 (de) * | 1991-12-02 | 2008-09-15 | Medical Res Council | Herstellung von autoantikörpern auf phagenoberflächen ausgehend von antikörpersegmentbibliotheken |
AU3719395A (en) * | 1994-09-21 | 1996-04-09 | Cytogen Corporation | Antigen binding peptides (abtides) from peptide libraries |
US5885577A (en) * | 1994-09-21 | 1999-03-23 | Cytogen Corporation | Antigen binding peptides (abtides) from peptide libraries |
US20010053523A1 (en) * | 1995-06-02 | 2001-12-20 | M&E Biotech A/S. | Method for identification of biologically active peptides and nucleic acids |
ES2200150T3 (es) | 1996-01-23 | 2004-03-01 | The Board Of Trustees Of The Leland Stanford Junior University | Procedimiento de cribaje de peptidos efectores transdominantes y moleculas de arn. |
US6365344B1 (en) * | 1996-01-23 | 2002-04-02 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for screening for transdominant effector peptides and RNA molecules |
US7045363B2 (en) | 1996-05-01 | 2006-05-16 | Fujirebio Inc. | Nucleic acid-bound polypeptide method of producing nucleic acid-bound polypeptide and immunoassay using the polypeptide |
WO1997045538A1 (en) * | 1996-05-31 | 1997-12-04 | Medigene Ag | Novel synthetic protein structural templates for the generation, screening and evolution of functional molecular surfaces |
NZ500656A (en) * | 1997-05-12 | 2001-11-30 | Tno | Vector containing a nucleic acid insertion expressing a hybrid polypeptide with a protease inhibitor domain and a receptor binding domain |
SE520302C2 (sv) * | 1997-09-15 | 2003-06-24 | Vito | Metalljonspecifik kapacitanssensor |
GB0029407D0 (en) * | 2000-12-01 | 2001-01-17 | Affitech As | Product |
US20050074865A1 (en) * | 2002-08-27 | 2005-04-07 | Compound Therapeutics, Inc. | Adzymes and uses thereof |
JP2005537032A (ja) * | 2002-08-27 | 2005-12-08 | コンパウンド セラピューティクス インコーポレーティッド | アドザイムおよびその用途 |
WO2005014649A2 (en) * | 2003-08-08 | 2005-02-17 | Pharmacia Corporation | Method for the preparation of molecules having antibody activity |
SG153855A1 (en) * | 2004-02-05 | 2009-07-29 | Massachusetts Inst Technology | Cell display libraries |
WO2007069604A1 (ja) * | 2005-12-14 | 2007-06-21 | National University Corporation Hokkaido University | 修飾蛋白質の製造方法 |
WO2009078018A2 (en) * | 2007-12-17 | 2009-06-25 | Affisink Biotechnology Ltd. | Methods for purifying or depleting molecules or cells of interest |
KR200479239Y1 (ko) * | 2014-08-07 | 2016-01-07 | 노진솔 | 팔 부위에 착용할 수 있는 패션 장식물 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1200773A (en) * | 1980-02-29 | 1986-02-18 | William J. Rutter | Expression linkers |
US4732864A (en) * | 1983-10-06 | 1988-03-22 | E. I. Du Pont De Nemours And Company | Trace-labeled conjugates of metallothionein and target-seeking biologically active molecules |
DE229046T1 (de) * | 1985-03-30 | 1987-12-17 | Marc Genf/Geneve Ballivet | Verfahren zum erhalten von dns, rns, peptiden, polypeptiden oder proteinen durch dns-rekombinant-verfahren. |
US4859609A (en) * | 1986-04-30 | 1989-08-22 | Genentech, Inc. | Novel receptors for efficient determination of ligands and their antagonists or agonists |
US5071773A (en) * | 1986-10-24 | 1991-12-10 | The Salk Institute For Biological Studies | Hormone receptor-related bioassays |
DE3852304T3 (de) * | 1987-03-02 | 1999-07-01 | Enzon Labs Inc., Piscataway, N.J. | Organismus als Träger für "Single Chain Antibody Domain (SCAD)". |
US4951955A (en) * | 1987-10-16 | 1990-08-28 | Sakamaki Mfg. Co., Ltd. | Chuck for tools |
US5223409A (en) * | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
US5217867A (en) * | 1988-11-30 | 1993-06-08 | The Salk Institute For Biological Studies | Receptors: their identification, characterization, preparation and use |
US5096815A (en) * | 1989-01-06 | 1992-03-17 | Protein Engineering Corporation | Generation and selection of novel dna-binding proteins and polypeptides |
US5198346A (en) * | 1989-01-06 | 1993-03-30 | Protein Engineering Corp. | Generation and selection of novel DNA-binding proteins and polypeptides |
-
1991
- 1991-02-14 DE DE69132902T patent/DE69132902D1/de not_active Expired - Lifetime
- 1991-02-14 EP EP91904817A patent/EP0515516B1/de not_active Expired - Lifetime
- 1991-02-14 CA CA002075974A patent/CA2075974C/en not_active Expired - Fee Related
- 1991-02-14 JP JP3505570A patent/JP3043407B2/ja not_active Expired - Lifetime
- 1991-02-14 SG SG1996008235A patent/SG65593A1/en unknown
- 1991-02-14 AT AT91904817T patent/ATE212059T1/de not_active IP Right Cessation
- 1991-02-14 WO PCT/US1991/001013 patent/WO1991012328A1/en active IP Right Grant
-
1995
- 1995-04-11 US US08/420,945 patent/US5935823A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2075974C (en) | 2001-02-06 |
WO1991012328A1 (en) | 1991-08-22 |
US5935823A (en) | 1999-08-10 |
EP0515516A1 (de) | 1992-12-02 |
EP0515516B1 (de) | 2002-01-16 |
CA2075974A1 (en) | 1991-08-16 |
EP0515516A4 (en) | 1993-03-31 |
DE69132902D1 (de) | 2002-02-21 |
JPH05503430A (ja) | 1993-06-10 |
ATE212059T1 (de) | 2002-02-15 |
JP3043407B2 (ja) | 2000-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG65593A1 (en) | Totally synthetic affinity reagents | |
CA2155185A1 (en) | Totally synthetic affinity reagents | |
WO1991008298A3 (en) | Fusion proteins consisting of a ligand binding protein and a stable plasma protein | |
EP0330451A3 (de) | Für menschliches Normal-Serumalbumin kodierende cDNA und Verfahren zur Herstellung des Albumins | |
IL130403A (en) | Oil bodies and associated proteins as affinity matrices | |
NZ233642A (en) | Linked hemoglobin subunits, preparation by genetic engineering and linker assay | |
EA200001023A1 (ru) | Специфическое в отношении fapa-(протеин альфа активации фибробласта) антитело с повышенной продуктивностью | |
DE68918867D1 (de) | Mutanten des hiv-1 Hüllproteins mit fehlenden hypervariabelen domänen. | |
IL87628A0 (en) | Stabilised human protein preparations and process for the production thereof | |
HK1040093A1 (en) | Method of enhancing the biological activity of ligands. | |
WO2000015659A3 (en) | Stomach polypeptide zsig28 | |
PT635025E (pt) | Processo para preparar proteinas modificadas | |
ES2192199T3 (es) | Ligandos de la familia eph biologicamente activos. | |
EP0546087A4 (de) | ||
TR200200048T2 (tr) | Otoproteolitik klevaj vasıtasıyla proteinlerin üretimi. | |
DK38889A (da) | Onkogen-indkodet polypeptid med vaekstfaktoraktivitet | |
EP0315118A3 (de) | Endothelin kodierendes DNA und dessen Verwendung | |
KR890008166A (ko) | 융합 단백질의 선택적 분해 방법 | |
ATE25708T1 (de) | Biologisch aktive konjugate, ihre herstellung und ihre anwendung. | |
AU637589B2 (en) | Ancrod proteins, their production and use | |
MX9700941A (es) | Materiales y metodos para la produccion de icam-4. | |
ATE293163T1 (de) | Cyclin e spezifische konstrukte und komplexe | |
SE8403929D0 (sv) | Recombinant dna molecule, transformed microorganisms and process for producing penicillin v amidase | |
EP0343132A3 (en) | Methods and systems for producing hiv antigens | |
ATE130872T1 (de) | Ancrod ähnliche proteine, ihre herstellung und verwendung. |